Position in PTGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$461,513
+$64,682 QoQ
Shares Held
3,765
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#220
of 343 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vestcor Inc holds $65,816,304 across 34 Biotechnology names. PTGX ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,242 | $13,531,918 | |
| 2 | INCY |
Incyte Corp
|
114,821 | $13,016,108 | |
| 3 | EXEL |
Exelixis, Inc.
|
132,700 | $7,220,207 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
50,000 | $6,636,500 | |
| 5 | TECH |
BIO-TECHNE Corp
|
90,000 | $6,358,500 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,959 | $2,640,790 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
119,319 | $2,024,843 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,060 | $1,824,241 |
All Filings in PTGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $461,513 | 3,765 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $396,831 | 3,765 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $328,835 | 3,765 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $333,611 | 5,022 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||